12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga · 5d ago
Gainers
- Regencell Bioscience (NASDAQ:RGC) shares rose 125.8% to $209.7 during Tuesday's regular session. The market value of their outstanding shares is at $2.7 billion.
- China SXT Pharmaceuticals (NASDAQ:SXTC) shares increased by 32.66% to $1.87. The company's market cap stands at $25.7 million.
- Tiziana Life Sciences (NASDAQ:TLSA) shares moved upwards by 28.27% to $1.56. The company's market cap stands at $182.8 million.
- CareCloud (NASDAQ:CCLD) stock moved upwards by 26.68% to $2.22. The company's market cap stands at $93.8 million. The company's, Q1 earnings came out today.
- Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock moved upwards by 20.02% to $0.36. The market value of their outstanding shares is at $4.9 million.
- AquaBounty Techs (NASDAQ:AQB) stock increased by 18.37% to $0.76. The market value of their outstanding shares is at $2.9 million.
Losers
- NuCana (NASDAQ:NCNA) stock declined by 67.2% to $0.36 during Tuesday's regular session. The market value of their outstanding shares is at $2.1 million.
- bioAffinity Technologies (NASDAQ:BIAF) stock fell 44.74% to $0.21. The company's market cap stands at $3.8 million.
- Tactile Systems Tech (NASDAQ:TCMD) stock decreased by 31.53% to $9.54. The company's market cap stands at $225.8 million. The company's, Q1 earnings came out yesterday.
- Kodiak Sciences (NASDAQ:KOD) shares fell 21.24% to $3.88. The company's market cap stands at $204.4 million.
- Syndax Pharmaceuticals (NASDAQ:SNDX) shares declined by 21.15% to $10.7. The company's market cap stands at $913.3 million. The company's, Q1 earnings came out yesterday.
- HealthStream (NASDAQ:HSTM) shares fell 18.75% to $27.01. The company's market cap stands at $824.4 million. As per the press release, Q1 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.